抗EGFL7抗体を用いた治療のための投与

Title:

抗EGFL7抗体を用いた治療のための投与

Document Type and Number:

Japanese Patent JP2014510044

Kind Code:

A

Abstract:

The present invention concerns dosing of anti-EGFL7 antibodies for cancer therapy.

More Like This:

JP2023527059	Compositions Containing Antibodies Against Interleukin-6 Receptors and Methods of Using Them to Treat Rheumatoid Arthritis
JP2021054866	METHODS AND COMPOSITIONS FOR TREATING SIGLEC-8 ASSOCIATED DISEASES

Inventors:

Bye, Shore
Chen, Daniel S.
Funke, Roel
Hegre, Pridy
Naumovski, Loei

Application Number:

JP2013552611A

Publication Date:

April 24, 2014

Filing Date:

February 01, 2012

Export Citation:

Assignee:

Genentech, Incorporated

International Classes:

A61K39/395; A61K31/282; A61K31/337; A61K31/513; A61K31/519; A61K45/00; A61P35/00; A61P43/00; C07K16/22

Attorney, Agent or Firm:

Sonoda Yoshitaka
Kobayashi Yoshinori

Previous Patent: JP2014510043

Next Patent: ヒアルロナン分解酵素の組成物および脂質製剤ならびに良性前立腺肥大症�...